Education
About Us
Working with TipRanks
Follow Us
Microbot Medical (MBOT)
:MBOT
MBOT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.82 - $3.38
Previous CloseN/A
Volume6.51M
Average Volume (3M)1.39M
Market Cap
$55.24M
Enterprise ValueN/A
Total Cash (Recent Filing)$5.24M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.61
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.80
Shares Outstanding34,744,476
10 Day Avg. Volume954,430
30 Day Avg. Volume1,386,858
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$9.00Price Target Upside492.11% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Microbot Medical News
PremiumCompany Announcements
Microbot Medical Appoints New VP Ahead of Product Launch
PremiumCompany Announcements
Microbot Medical Advances in Robotic Telesurgery Research
PremiumCompany Announcements
Microbot Medical Closes $13M Offering for Expansion
PremiumCompany Announcements
Microbot Medical Enters Material Definitive Agreement---
Ownership Overview
0.39%
Insiders
1.79% Mutual Funds
0.64% Other Institutional Investors
95.64% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MBOT FAQ
What was Microbot Medical’s price range in the past 12 months?
Microbot Medical lowest stock price was $0.82 and its highest was $3.38 in the past 12 months.
What is Microbot Medical’s market cap?
Microbot Medical’s market cap is $55.24M.
When is Microbot Medical’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Microbot Medical’s earnings last quarter?
Microbot Medical released its earnings results on Apr 14, 2020. The company reported -$0.31 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.31.
Is Microbot Medical overvalued?
According to Wall Street analysts Microbot Medical’s price is currently Undervalued.
Does Microbot Medical pay dividends?
Microbot Medical does not currently pay dividends.
What is Microbot Medical’s EPS estimate?
Microbot Medical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Microbot Medical have?
Microbot Medical has 34,744,476 shares outstanding.
What happened to Microbot Medical’s price movement after its last earnings report?
Microbot Medical reported an EPS of -$0.31 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Microbot Medical?
Currently, no hedge funds are holding shares in MBOT
---
Microbot Medical Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$9.00 (492.11% Upside)
$9.00 (492.11% Upside)
Crowd Wisdom
Neutral
Last 7 Days ▲ 1.4%
Last 30 Days ▼ 1.2%
Last 30 Days ▼ 1.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
35.11%
12-Months-Change
Fundamentals
Return on Equity
-284.97%
Trailing 12-Months
Asset Growth
-27.57%
Trailing 12-Months
Company Description
Microbot Medical
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
---
MBOT Stock 12 Month Forecast
Average Price Target
$9.00
▲(492.11% Upside)
Technical Analysis
Best Analysts Covering MBOT
1 Year
1 Year Success Rate
2/6 ratings generated profit
1 Year Average Return
-17.97%
reiterated a buy rating 2 months ago
Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -17.97% per trade.
---